Clinical Trials · NCT00552071
Ultrasound Guided Octreotide LAR Injection in Acromegaly
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Cedars-Sinai Medical Center
- Enrollment
- 15
- Start date
- Jul 2007
- Locations
- 1 site, United States
- Primary endpoint
- Plasma Octreotide Level After Each Treatment Phase